BLUEBERRIES MEDICAL CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.015 CAD | -.--% |
|
-.--% | -25.00% |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Capitalization 1 | 14.84 | 12.67 | 11.47 | 4.366 | 7.981 |
| Enterprise Value (EV) 1 | 13.02 | 13.86 | 11.56 | 4.29 | 7.175 |
| P/E ratio | -1.21 x | -2.51 x | -2.02 x | -2.3 x | -2.68 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 192,036,482 x | 82,644,800 x | 18,544,071 x | 27,683,934 x |
| EV / Revenue | - | 210,005,896 x | 83,334,559 x | 18,219,899 x | 24,890,204 x |
| EV / EBITDA | -1.99 x | -3.88 x | -10.7 x | -3.18 x | -5.84 x |
| EV / FCF | -2,290,165 x | -13,954,160 x | -5,726,808 x | -2,779,429 x | -5,996,220 x |
| FCF Yield | -0% | -0% | -0% | -0% | -0% |
| Price to Book | 1.84 x | 3.26 x | 7.99 x | 2.97 x | 4.1 x |
| Nbr of stocks (in thousands) | 123,702 | 126,702 | 163,810 | 218,309 | 399,025 |
| Reference price 2 | 0.1200 | 0.1000 | 0.0700 | 0.0200 | 0.0200 |
| Announcement Date | 4/29/20 | 4/30/21 | 5/3/22 | 4/24/23 | 4/26/24 |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | 0.066 | 0.1387 | 0.2354 | 0.2883 |
| EBITDA 1 | -1.599 | -6.533 | -3.571 | -1.085 | -1.349 | -1.228 |
| EBIT 1 | -1.617 | -6.799 | -4.125 | -1.789 | -1.641 | -1.376 |
| Operating Margin | - | - | -6,251.54% | -1,289.55% | -696.79% | -477.44% |
| Earnings before Tax (EBT) 1 | -1.607 | -10.79 | -4.94 | -5.147 | -1.468 | -1.635 |
| Net income 1 | -1.607 | -10.79 | -4.94 | -5.147 | -1.468 | -1.635 |
| Net margin | - | - | -7,487.51% | -3,709.64% | -623.44% | -567.3% |
| EPS 2 | -0.0334 | -0.0990 | -0.0399 | -0.0347 | -0.008691 | -0.007457 |
| Free Cash Flow | - | -5.685 | -0.9929 | -2.019 | -1.543 | -1.197 |
| FCF margin | - | - | -1,504.97% | -1,455.17% | -655.53% | -415.1% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/23/19 | 4/29/20 | 4/30/21 | 5/3/22 | 4/24/23 | 4/26/24 |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 0.02 | - | 1.19 | 0.1 | - | - |
| Net Cash position 1 | - | 1.83 | - | - | 0.08 | 0.81 |
| Leverage (Debt/EBITDA) | -0.0107 x | - | -0.332 x | -0.0882 x | - | - |
| Free Cash Flow | - | -5.68 | -0.99 | -2.02 | -1.54 | -1.2 |
| ROE (net income / shareholders' equity) | - | -235% | -82.6% | -193% | -101% | -95.8% |
| ROA (Net income/ Total Assets) | - | -72.9% | -30.2% | -20.6% | -29.5% | -29.8% |
| Assets 1 | - | 14.79 | 16.34 | 25 | 4.973 | 5.486 |
| Book Value Per Share 2 | 0.0200 | 0.0700 | 0.0300 | 0.0100 | 0.0100 | 0 |
| Cash Flow per Share 2 | 0.0100 | 0.0200 | 0 | 0.0100 | 0.0100 | 0 |
| Capex 1 | 0.04 | 4.52 | 0.83 | 0.01 | - | 0.02 |
| Capex / Sales | - | - | 1,261.29% | 6.88% | - | 7.75% |
| Announcement Date | 4/23/19 | 4/29/20 | 4/30/21 | 5/3/22 | 4/24/23 | 4/26/24 |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -25.00% | 4.35M | |
| +41.56% | 3.65B | |
| +15.65% | 2.15B | |
| +118.82% | 741M | |
| +34.09% | 625M | |
| +48.36% | 182M | |
| +8.64% | 104M | |
| +57.30% | 58.4M |
- Stock Market
- Equities
- BBM Stock
- Financials Blueberries Medical Corp.
